Track 12: Value and Access
The healthcare landscape is evolving into one assessed on value, and there is a need to understand the impact of this movement on all stakeholders – providers, payers, biopharma, and ultimately patients. The Value and Access track will bring together global regulators, industry leaders, patients, and payers who will facilitate discussions and address questions such as:
- What information and evidence is being used to define value?
- Who is making or influencing access decisions?
- How can real-world data be leveraged to drive access to medicines?
- What are the regulatory and legal considerations surrounding value-based contracting conversations with payers?
Sessions in Value and Access
Sunday, June 23 | Short Courses
- Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies
Monday, June 24
- FDA Payer Communication Guidance, Twenty Years in the Making: Now What?
- Making Value-Based Contracting Stick
- Making Early Access for Patients Happen
Tuesday, June 25
- Personalized Healthcare and Clinical Outcomes: How Real World Endpoints Can Improve Approval and Access to Medicine?
- How Employers Are Reinventing Healthcare and what it Means for Research Participation and Evidence
- Aligning Facilitated Regulatory and Access Pathways: Observations from the North American Experience
- Public and Regulatory Response to Drug Pricing Concerns
Wednesday, June 26
- How to Solve the Problem of Access for Rare Diseases
- Opportunities and Challenges of Collecting Data in a Pre-Approval Access Setting: A Multi-Stakeholder Perspective
- Advancing Value and Access with Technology
- Challenges to Access: Bringing Payers to the Table
View one of our video interviews from DIA 2018 with DIA Senior Scientist Inka Heikkinen as she discusses the sustainability of healthcare funding with Kenneth Kaitin, Tufts University School of Medicine, and Luca Pani, University of Miami, to complement the Unmet Medical Need series at DIA 2018.
Who is This Track Designed For?
Professionals involved in: Health economics outcomes, statistics, data modeling, clinical research, post-marketing, regulatory affairs, and health economy.